SWK HOLDINGS DL-,001

SWK Holdings completed its merger with Runway Growth Finance and became a wholly owned subsidiary of Runway. Shareholders could elect to receive 1.7264 Runway common shares per SWK share or $20.59 in cash; Runway issued about 6.33 million shares and paid $173.54 million in cash. SWK filed for the delisting of its common shares and the suspension of SEC reporting obligations, all incumbent executives resigned, outstanding liabilities were fully repaid, and bond terms were adjusted to comply with the Investment Company Act. » Więcej na de.investing.com

SWK Holdings reports the full repayment of a loan to Elutia of USD 27.8 million, including principal, exit fees and accrued interest. The payment follows Elutia’s sale of its BioEnvelope business to Boston Scientific for USD 88.0 million. SWK says the receipt exceeds the loan’s net carrying value under GAAP and expects additional income from accelerated exit fees and the release of risk reserves. SWK also beat earnings expectations in Q2 2025 with earnings per share of USD 0.38. » Więcej na de.investing.com

SWK Holdings reported Q2 2025 EPS of $0.38, topping the $0.24 estimate. Cost cuts and asset sales produced GAAP pre-tax income of $4.6 million and net income of $3.5 million. The company paid $49 million in dividends, sharply reduced operating expenses and expects transitions in Q3 related to the sale of "Mod three." Despite the positive results, the stock fell in after-hours and pre-market trading, which investors say reflects concerns about the strategic realignment and regulatory risks. » Więcej na de.investing.com